Determination of Sensitive Skin and Its Biophysical Response in a Latin-American Population
|ClinicalTrials.gov Identifier: NCT01591993|
Recruitment Status : Completed
First Posted : May 4, 2012
Last Update Posted : November 29, 2012
Sensitive skin syndrome is a frequent self-diagnosed entity that has not been previously described in a Latin-american population. One hypothesis to its development is an alteration of the barrier function of the skin. The aim of the study is to describe the frequency of sensitive skin in a mexican population detected through the lactic acid test, and to explore its response through biophysical measures (colorimetry, transepidermal water loss (TEWL) and capacitance). The prevalence of this syndrome in studied populations is approximately 50%. Considering racial skin differences, the investigators would expect at least a 20% prevalence.
For this purpose, the investigators would need a minimum of 243 healthy volunteers, 18 years or older, with previous informed consent, to whom the lactic acid test will be performed. The investigators will record any unpleasant sensation graded in a Visual Analog Scale (VAS) of 10 points, colorimetry, TEWL and capacitance before the test and at 3, 5, 8 and 10 minutes after the lactic acid test.
|Condition or disease||Intervention/treatment||Phase|
|Skin Irritancy Tests||Procedure: 10% lactic acid test Procedure: Placebo||Phase 4|
Sensitive skin is defined as the presence of itching, stinging, burning or other unpleasant sensations due to external factors (such as light, heat, cold, air, cosmetic products, soap, water and even emotional and hormonal factors). By definition it is a subjective syndrome, where there are no clinical signs, making it a self-diagnosed entity. Previous community-based studies, mostly in caucasians, have found a high prevalence in general population. Nonetheless, to date there are only a few studies and with a small amount of subjects that have applied an objective test to identify this syndrome, and even fewer have explored the possible alterations associated to it.
The investigators aim to describe the frequency in a hispanic population, and further explore the presence of alterations in the barrier function through measurement of TEWL and capacitance, as well as possible subclinical erythema (a* axis of colorimetry) or variations due to skin pigmentation (L* axis).
The volunteers in the study will be randomized to receive in one nasolabial fold 10% lactic acid solution, and placebo (0.9% saline solution) in the other to act as the control. The investigators will be grading any unpleasant sensation in a 10-point scale (VAS) at 4 different time intervals: 3, 5, 8 and 10 minutes. The investigators will be measuring colorimetry (ChromaMeter CR-300 (Minolta, Japan)), TEWL (Evaporimeter DermaLab (Cortex Technology, Denmark)) and capacitance (Corneometer DermaLab Moisture Module (Cortex Technology, Denmark)) before performing the test, and at 3, 5, 8 and 10 minutes after it. These time intervals have been previously determined according to previous reports where the maximum intensity of the response is obtained in the first 5 minutes, and after 10 minutes the response gradually diminishes.
Statistical analysis will be performed with square chi test, t-test or U-Mann-Whitney, according to the parametric or non-parametric distribution of the values. All tests will be performed using the JMP software 8.0 (Cary, NC, USA) at 95% of confidence, statistical significance at 5% with 80% power.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||260 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Investigator, Outcomes Assessor)|
|Official Title:||Determination of Sensitive Skin in a Mexican Population by Lactic Acid Testing and Its Analysis Through Biophysical Measures|
|Study Start Date :||October 2011|
|Primary Completion Date :||May 2012|
|Study Completion Date :||August 2012|
Experimental: Test subject
To each subject, the investigators will randomly apply 10% lactic acid on one nasolabial fold, once.
Procedure: 10% lactic acid test
To each subject, 10% lactic acid is applied to one nasolabial fold. This will be performed under humidity, temperature and pH control to avoid influence of these variables in the result of the test.
Placebo Comparator: Placebo
To each subject, the investigators will apply placebo (0.9% saline solution) on the contralateral nasolabial fold to the lactic acid, simultaneously.
To each subject, 0.9% saline solution will be applied to the contralateral nasolabial fold. This will be performed under humidity, temperature and pH control to avoid influence of these variables in the result of the test.
- Sensitivity to lactic acid [ Time Frame: 10 minutes ]Identify and measure the presence of any unpleasant sensation after the application of 10% lactic acid test to the nasolabial fold. Will serve to identify subjects with sensitive skin.
- Erythema [ Time Frame: 0, 3, 5, 8 and 10 minutes ]Measure the presence of erythema through colorimetry (a* axis).
- Skin pigmentation [ Time Frame: 0 minutes ]Measure the melanin angle (through L* axis) before performing the test.
- Transepidermal water loss [ Time Frame: 0, 3, 5, 8 and 10 minutes ]Quantify the change in TEWL by evaporimetry in grams per squared meter per hour, as an indirect measure of skin barrier disfunction.
- Capacitance [ Time Frame: 0, 3, 5, 8, 10 minutes ]Quantify the change in capacitance by corneometry, as an indirect measure of skin barrier disfunction.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01591993
|Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto"|
|San Luis Potosí, Mexico, 78210|
|Principal Investigator:||Diana V Hernández-Blanco, MD||Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto"|
|Principal Investigator:||Adriana Ehnis-Pérez, MD||Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto"|
|Study Director:||Juan P Castanedo-Cázares, MD||Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto"|
|Study Chair:||Bertha Torres-Álvarez, MD||Dermatology Department. Hospital Central "Dr. Ignacio Morones Prieto"|